Simplex Trading
XBI icon

Simplex Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Simplex Trading’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-241,039
Closed -$19.5M – 9877
2025
Q1 		$19.5M Sell
241,039
-61,655
-20% -$5.51M 0.01% 539
2024
Q4 		$27.3M Buy
+302,694
New +$29.3M 0.02% 494
2024
Q2 		– Sell
-188,115
Closed -$17.9M – 9976
2024
Q1 		$17.9M Buy
+188,115
New +$17.5M 0.01% 768
2023
Q3 		– Sell
-116,879
Closed -$9.72M – 9996
2023
Q2 		$9.72M Buy
116,879
+37,260
+47% +$3.12M 0.01% 906
2023
Q1 		$6.07M Buy
79,619
+11,288
+17% +$937K 0.01% 1177
2022
Q4 		$5.67M Sell
68,331
-14,190
-17% -$1.15M 0.01% 1146
2022
Q3 		$6.54M Buy
+82,521
New +$6.96M 0.01% 1032
2021
Q4 		– Sell
-33,018
Closed -$4.57M – 11596
2021
Q3 		$4.57M Buy
33,018
+435
+1% +$56K ﹤0.01% 1287
2021
Q2 		$4.41M Buy
32,583
+24,792
+318% +$3.26M ﹤0.01% 1293
2021
Q1 		$1.06M Buy
+7,791
New +$1.17M ﹤0.01% 2334
2019
Q1 		– Sell
-43,720
Closed -$3.14M – 7979
2018
Q4 		$3.14M Buy
+43,720
New +$3.52M 0.01% 817
2018
Q3 		– Sell
-35,406
Closed -$3.37M – 8171
2018
Q2 		$3.37M Buy
+35,406
New +$3.25M 0.01% 780
2017
Q2 		– Sell
-13,297
Closed -$922K – 6889
2017
Q1 		$922K Buy
13,297
+13,047
+5,219% +$876K 0.04% 417
2016
Q4 		$14K Buy
+250
New +$15.4K ﹤0.01% 3420
2016
Q3 		– Sell
-1,054
Closed -$57K – 6550
2016
Q2 		$57K Sell
1,054
-8,319
-89% -$456K ﹤0.01% 1930
2016
Q1 		$484K Buy
9,373
+8,772
+1,460% +$456K 0.04% 458
2015
Q4 		$42K Sell
601
-3,222
-84% -$220K ﹤0.01% 2067
2015
Q3 		$237K Buy
+3,823
New +$301K 0.02% 811

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Simplex Trading's XBI Position: Q2 2025 in Review

Simplex Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 241,039 shares — an estimated $19.5M sold.

Simplex Trading first reported a position in XBI in Q3 2015 and held it in 18 quarters. The position peaked at $27.3M in Q4 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • Simplex Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • Simplex Trading sold 241,039 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $19.5M.
  • Simplex Trading first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 18 quarters.
  • Simplex Trading's State Street SPDR S&P Biotech ETF position peaked at $27.3M in Q4 2024.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.